337 related articles for article (PubMed ID: 15196911)
1. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
[TBL] [Abstract][Full Text] [Related]
2. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
Neese LL; Wolfe CA; Church FC
Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
[TBL] [Abstract][Full Text] [Related]
3. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
Whinna HC; Church FC
J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
[TBL] [Abstract][Full Text] [Related]
4. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
5. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
Myles T; Church FC; Whinna HC; Monard D; Stone SR
J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
Cooper ST; Rezaie AR; Esmon CT; Church FC
Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
[TBL] [Abstract][Full Text] [Related]
7. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
Holland CA; Henry AT; Whinna HC; Church FC
FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
[TBL] [Abstract][Full Text] [Related]
8. Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
Han JH; Tollefsen DM
Biochemistry; 1998 Mar; 37(9):3203-9. PubMed ID: 9485475
[TBL] [Abstract][Full Text] [Related]
9. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
Sutherland JS; Bhakta V; Filion ML; Sheffield WP
Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
[TBL] [Abstract][Full Text] [Related]
10. Serpin-glycosaminoglycan interactions.
Rein CM; Desai UR; Church FC
Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
[TBL] [Abstract][Full Text] [Related]
11. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
Mitchell JW; Church FC
J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
13. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
Boyle AJ; Roddick LA; Bhakta V; Lambourne MD; Junop MS; Liaw PC; Weitz JI; Sheffield WP
BMC Biochem; 2013 Mar; 14():6. PubMed ID: 23496873
[TBL] [Abstract][Full Text] [Related]
14. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.
Becker DL; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709
[TBL] [Abstract][Full Text] [Related]
15. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
Pratt CW; Church FC
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.
Verhamme IM
Anal Biochem; 2012 Feb; 421(2):489-98. PubMed ID: 22206940
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
18. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
Preissner KT; Sié P
Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
[TBL] [Abstract][Full Text] [Related]
19. Molecular mapping of the thrombin-heparin cofactor II complex.
Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
[TBL] [Abstract][Full Text] [Related]
20. Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
Sarilla S; Habib SY; Kravtsov DV; Matafonov A; Gailani D; Verhamme IM
J Biol Chem; 2010 Mar; 285(11):8278-89. PubMed ID: 20053992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]